These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesis. Brands M; Ergüden JK; Hashimoto K; Heimbach D; Schröder C; Siegel S; Stasch JP; Weigand S Bioorg Med Chem Lett; 2005 Oct; 15(19):4201-5. PubMed ID: 16085415 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities. De Tran Q; Bepary S; Lee GH; Cho H; Park WK; Lim HJ Bioorg Med Chem Lett; 2016 Jan; 26(1):51-4. PubMed ID: 26608551 [TBL] [Abstract][Full Text] [Related]
7. Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme. Ksander GM; Savage P; Trapani AJ; Balwierczak JL; Jeng AY J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S71-3. PubMed ID: 9595404 [TBL] [Abstract][Full Text] [Related]
8. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1. Takayanagi R; Liu W; Ito T; Ohnaka K; Nawata H J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S62-3. PubMed ID: 9595401 [TBL] [Abstract][Full Text] [Related]
9. Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung. Shiosaki K; Tasker AS; Sullivan GM; Sorensen BK; von Geldern TW; Wu-Wong JR; Marselle CA; Opgenorth TJ J Med Chem; 1993 Feb; 36(4):468-78. PubMed ID: 8474103 [TBL] [Abstract][Full Text] [Related]
10. N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities. Inguimbert N; Poras H; Teffo F; Beslot F; Selkti M; Tomas A; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP Bioorg Med Chem Lett; 2002 Aug; 12(15):2001-5. PubMed ID: 12113828 [TBL] [Abstract][Full Text] [Related]
11. [Synthesis and hemodynamic effects of the new inhibitor of endothelin converting enzyme]. Pozdnev VF; Gomazkov OA; Davydova MP; Medvedeva NA Biull Eksp Biol Med; 1998 Nov; 126(11):526-9. PubMed ID: 9883360 [No Abstract] [Full Text] [Related]
12. Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells. Berger Y; Dehmlow H; Blum-Kaelin D; Kitas EA; Löffler BM; Aebi JD; Juillerat-Jeanneret L J Med Chem; 2005 Jan; 48(2):483-98. PubMed ID: 15658862 [TBL] [Abstract][Full Text] [Related]
13. In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position. Inguimbert N; Poras H; Dhotel H; Beslot F; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP J Pept Res; 2004 Feb; 63(2):99-107. PubMed ID: 15009531 [TBL] [Abstract][Full Text] [Related]
14. [Study of substrate specificity of a new peptide substrate of endothelin converting enzyme]. Gureeva TA; Kugaevskaia EV; Pozdnev VF; Prozorovskiĭ VN; Eliseeva IuE; Solov'eva NI Biomed Khim; 2007; 53(2):172-80. PubMed ID: 17639718 [TBL] [Abstract][Full Text] [Related]
15. Potent triazolyl-proline-based inhibitors of HCV NS3 protease. Naud J; Lemke C; Goudreau N; Beaulieu E; White PD; Llinàs-Brunet M; Forgione P Bioorg Med Chem Lett; 2008 Jun; 18(11):3400-4. PubMed ID: 18448339 [TBL] [Abstract][Full Text] [Related]